| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mbx Biosciences, Inc. (MBX) has 8 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. MBX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.22M | $203.04M | - | |
| CEO | 486.8K | $18.94M | - | |
| 10% | 16.0K | $622.4K | - | |
| Dir | 16.0K | $622.4K | - | |
| Dir | 16.0K | $622.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Hawryluk P. Kent | President &CEO | Buy | 18,500 | $28.41 | $525,662.70 | +4.0% | - | - | |
| Oct 20, 2025 | Hawryluk P. Kent | President &CEO | Buy | 20,000 | $13.64 | $272,790.00 | +4.5% | +203.2% | - | |
| Oct 17, 2025 | Hoerter Steven L. | Director | Buy | 20,000 | $13.25 | $264,984.00 | New | +209.5% | - | |
| Sep 26, 2025 | Heron Patrick J86 | Director, 10% Owner | Buy | 666,666 | $18.00 | $11,999,988.00 | +14.6% | +76.5% | - | |
| Apr 8, 2025 | Pescovitz Ora H. | Director | Buy | 7,693 | $5.89 | $45,311.77 | +46.2% | +122.5% | +446.8% | |
| Feb 18, 2025 | Gordon Carl L74 | Director, 10% Owner | Buy | 190,672 | $10.60 | $2,020,755.60 | +1.9% | +11.5% | +269.8% | |
| Feb 18, 2025 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 190,672 | $10.60 | $2,020,755.60 | +1.9% | +11.5% | +269.8% | |
| Feb 4, 2025 | Hawryluk P. Kent | President &CEO | Buy | 50,000 | $10.69 | $534,500.00 | +12.6% | +10.4% | +251.1% | |
| Sep 16, 2024 | Behbahani Ali46 | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +16.1% | -11.6% | -55.0% | |
| Sep 16, 2024 | Gordon Carl L74 | Director, 10% Owner | Buy | 750,000 | $16.00 | $12,000,000.00 | +24.5% | -11.6% | -55.0% |